Skip to main content
. 2023 Jun 15;15(6):3960–3975.

Table 2.

Multinomial logistic regression of immune phenotype, immune cell level and tumor cell level in patients with metastatic urothelial cancer

Gene Immunophenotype

Desert Excluded Inflamed


OR (95% CI) P Value OR (95% CI) P Value

CXCL9 Reference 1.209 (0.727, 2.009) 0.465 1.314 (0.728, 2.373) 0.364
GBP5 2.594 (1.469, 4.581) 0.001 5.938 (2.868, 12.295) < 0.001
IFNG 0.217 (0.009, 5.137) 0.344 1.309 (0.047, 36.181) 0.874

Immune cell level

IC0 IC1 IC2+


OR (95% CI) P Value OR (95% CI) P Value

CXCL9 Reference 0.935 (0.581, 1.505) 0.781 1.984 (1.193, 3.301) 0.008
GBP5 2.740 (1.656, 4.534) < 0.001 2.403 (1.357, 4.255) 0.003
IFNG 1.030 (0.054, 19.642) 0.984 1.368 (0.069, 26.927) 0.837

Tumor cell level

TC0 TC1 TC2+


OR (95% CI) P Value OR (95% CI) P Value

CXCL9 Reference 1.242 (0.700, 2.203) 0.459 1.036 (0.725, 1.480) 0.848
GBP5 0.638 (0.312, 1.304) 0.218 2.033 (1.294, 3,195) 0.002
IFNG 7.498 (1.279, 43.954) 0.026 1.377 (0.369, 5.148) 0.634